[1]
T. Soysal, F. Ermis, and H. Ankarali, “α-Galactosidase levels in irritable bowel syndrome subtypes and quality of life of patients”, annalsmedres, vol. 28, no. 10, pp. 1881–1886, Oct. 2021.